|
Mar 3
|
Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's What You Should Know
|
|
Feb 27
|
Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
|
|
Feb 26
|
Disc Medicine to Participate in Upcoming Investor Conferences
|
|
Jan 1
|
An Intrinsic Calculation For Disc Medicine, Inc. (NASDAQ:IRON) Suggests It's 29% Undervalued
|
|
Oct 11
|
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week
|
|
Jun 14
|
Disc Medicine Announces Underwritten Offering of Common Stock
|
|
Jun 14
|
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
|
|
May 30
|
Disc Medicine to Participate in the Jefferies Global Healthcare Conference
|
|
May 14
|
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
|
|
May 13
|
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
|
|
May 11
|
Disc Medicine Inc (IRON) Reports Q1 2024 Earnings: A Detailed Financial Overview
|
|
May 9
|
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
Apr 4
|
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
|
|
Apr 2
|
Disc Medicine (IRON) Down on Mixed Results From AURORA Study
|
|
Apr 1
|
Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study
|
|
Apr 1
|
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
|
|
Mar 23
|
Disc Medicine Inc (IRON) Reports Earnings: A Detailed Look at Fiscal Performance
|
|
Mar 21
|
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
|
Mar 6
|
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
|
|
Dec 22
|
Peabody Energy, Janus International, and More Stocks See Action From Activist Investors
|